Status:
COMPLETED
DNA Cytometry for Cervical Cancer Screening in China
Lead Sponsor:
Nanjing Medical University
Conditions:
Cervical Cancer
Eligibility:
FEMALE
20-65 years
Brief Summary
Very few screenings of any kind will be possible during a woman's lifetime in most low-resource regions, where 80% of the half-million global cases of cervical cancer occur every year. Although a sing...
Eligibility Criteria
Inclusion
- Currently or had been married
- Not pregnant
- Had an intact uterus with no prolapse
- Had no history of cervical cancer
- Living in China
Exclusion
- Not willing to participate or finish the study at any time
- History of cervical surgeries
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
25000 Patients enrolled
Trial Details
Trial ID
NCT00902551
Start Date
January 1 2007
End Date
June 1 2009
Last Update
November 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Maternal and Child Health Care Hospital
Nanjing, Jiangsu, China, 210004